Noradrenalina Tartrato (Noradrenaline Tartrate)

Noradrenaline tartrate, the active ingredient in Noradrenalina Tartrato, is a vasopressor presented as an injection solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in acute hypotensive states such as septic shock, cardiogenic shock and cardiac arrest. GNH USA supplies Noradrenalina Tartrato as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenalina Tartrato is used as a potent vasopressor in critical care settings to support circulatory function. - Hypotension: restores arterial pressure and organ perfusion. - Septic shock: counteracts vasodilatory failure and improves hemodynamics. - Cardiogenic shock: enhances myocardial contractility and systemic vascular resistance. - Cardiac arrest: provides immediate pressor support during resuscitation efforts.

Adverse reactions may occur with intravenous norepinephrine administration.

Common Side Effects: - Tachycardia: increased heart rate due to beta‑1 stimulation. - Hypertension: excessive rise in blood pressure from alpha‑1 vasoconstriction. - Headache: secondary to elevated arterial pressure. - Nausea or vomiting: gastrointestinal discomfort. - Peripheral ischemia: reduced blood flow to extremities.

Serious or Rare Side Effects: - Arrhythmias: potentially life‑threatening cardiac rhythm disturbances. - Myocardial ischemia: reduced coronary perfusion from intense vasoconstriction. - Tissue necrosis: extravasation causing local tissue injury. - Severe hypertension: risk of cerebrovascular events. - Pulmonary edema: fluid accumulation due to increased afterload.

Noradrenalina Tartrato requires careful monitoring and specific safety measures in clinical use. - Blood pressure monitoring: adjust infusion to maintain target MAP. - Cardiac function assessment: watch for tachyarrhythmias and ischemia. - Dose titration: start low and increase gradually based on response. - Caution in arrhythmia patients: avoid rapid dose escalations. - Extravasation risk: use central venous access when possible. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline may interact with several drug classes, influencing its pressor effect or safety profile.

Major Interactions (Avoid): - MAO inhibitors: can cause hypertensive crisis due to excess catecholamines. - Ergot alkaloids: risk of severe vasospasm and ischemia. - Other potent vasopressors: may lead to excessive hypertension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt beta‑1 mediated cardiac effects. - ACE inhibitors or ARBs: can attenuate blood pressure response. - Diuretics: may potentiate volume depletion and hypotension.